Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Jessica K, Dyson"'
Publikováno v:
BMC Medical Genomics, Vol 17, Iss 1, Pp 1-13 (2024)
Abstract Primary Sclerosing Cholangitis (PSC) is a progressive cholestatic liver disease with no licensed therapies. Previous Genome Wide Association Studies (GWAS) have identified genes that correlate significantly with PSC, and these were identifie
Externí odkaz:
https://doaj.org/article/c1bcbcd837f34175b375f4daaba3d662
Autor:
Laura Martinez-Gili, Alexandros Pechlivanis, Julie A.K. McDonald, Sofina Begum, Jonathan Badrock, Jessica K. Dyson, Rebecca Jones, Gideon Hirschfield, Stephen D. Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D. Taylor-Robinson, Mary M.E. Crossey, Julian R. Marchesi, George Mells, Elaine Holmes, David Jones
Publikováno v:
Gut Microbes, Vol 15, Iss 1 (2023)
ABSTRACTPrimary biliary cholangitis (PBC) is a chronic cholestatic liver disease with ursodeoxycholic acid (UDCA) as first-line treatment. Poor response to UDCA is associated with a higher risk of progressing to cirrhosis, but the underlying mechanis
Externí odkaz:
https://doaj.org/article/96120242cd9d46b48c536c4461b39cb1
Autor:
David E.J. Jones, Aaron Wetten, Ben Barron-Millar, Laura Ogle, George Mells, Steven Flack, Richard Sandford, John Kirby, Jeremy Palmer, Sophie Brotherston, Laura Jopson, John Brain, Graham R. Smith, Steve Rushton, Rebecca Jones, Simon Rushbrook, Douglas Thorburn, Stephen D. Ryder, Gideon Hirschfield, Jessica K. Dyson
Publikováno v:
EBioMedicine, Vol 80, Iss , Pp 104068- (2022)
Summary: Background: Uncertainty exists about how best to identify primary biliary cholangitis (PBC) patients who would benefit from second-line therapy. Existing, purely clinical, ursodeoxycholic acid (UDCA) response criteria accept degrees of liver
Externí odkaz:
https://doaj.org/article/39a878808f5b4982bbbea7ab6978ff11
Autor:
Aaron Wetten, Laura Ogle, George Mells, Vinod S. Hegade, Laura Jopson, Margaret Corrigan, Jeremy Palmer, Maja Johansson, Torbjörn Bäckström, Magnus Doverskog, David E. J. Jones, Jessica K. Dyson
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2022 (2022)
Background and Aims. A third of patients with primary biliary cholangitis (PBC) experience poorly understood cognitive symptoms, with a significant impact on quality of life (QOL), and no effective medical treatment. Allopregnanolone, a neurosteroid,
Externí odkaz:
https://doaj.org/article/9fcfa82491ac470e963dd7cf21e73f2a
Autor:
Lucy M.V. Gee, Ben Barron-Millar, Jack Leslie, Claire Richardson, Marco Y.W. Zaki, Saimir Luli, Rachel A. Burgoyne, Rainie I.T. Cameron, Graham R. Smith, John G. Brain, Barbara Innes, Laura Jopson, Jessica K. Dyson, Katherine R.C. McKay, Alexandros Pechlivanis, Elaine Holmes, Rolando Berlinguer-Palmini, Stella Victorelli, George F. Mells, Richard N. Sandford, Jeremy Palmer, John A. Kirby, Christos Kiourtis, Joao Mokochinski, Zoe Hall, Thomas G. Bird, Lee A. Borthwick, Christopher M. Morris, Peter S. Hanson, Diana Jurk, Elizabeth A. Stoll, Fiona E.N. LeBeau, David E.J. Jones, Fiona Oakley
Publikováno v:
Gee, L M V, Barron-Millar, B, Leslie, J, Richardson, C, Zaki, M Y W, Luli, S, Burgoyne, R, Cameron, R I T, Smith, G R, Brain, J G, Innes, B, Jopson, L, Dyson, J K, McKay, K R C, Pechlivanis, A, Holmes, E, Berlinguer-Palmini, R, Victorelli, S, Mells, G F, Sandford, R N, Palmer, J, Kirby, J, Kiourtis, C, Mokochinski, J, Hall, Z, Bird, T G, Borthwick, L A, Morris, C, Hanson, P, Jurk, D, Stoll, E, LeBeau, F, Jones, D & Oakley, F 2022, ' Anti-Cholestatic therapy with Obeticholic Acid improves short term memory in bile duct ligated mice ', The American Journal of Pathology . https://doi.org/10.1016/j.ajpath.2022.09.005
Patients with cholestatic liver disease, including those with primary biliary cholangitis, can experience symptoms of impaired cognition or brain fog. This phenomenon remains unexplained and is currently untreatable. Bile duct ligation (BDL) is an es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a70d70f37cc3ec34fd9fc440f82313fc
Autor:
Nadir Abbas, Emma L. Culver, Douglas Thorburn, Neil Halliday, Hannah Crothers, Jessica K. Dyson, April Phaw, Richard Aspinall, Salim I. Khakoo, Yiannis Kallis, Belinda Smith, Imran Patanwala, Anne McCune, Chenchu R. Chimakurthi, Vinod Hegade, Michael Orrell, Rebecca Jones, George Mells, Colette Thain, Robert-Mitchell Thain, David Jones, Gideon Hirschfield, Palak J. Trivedi
Publikováno v:
Clinical Gastroenterology and Hepatology. 21:1561-1570.e13
Thirty-to-forty percent of patients with primary biliary cholangitis inadequately respond to ursodeoxycholic acid. Our aim was to assemble national, real-world data on the effectiveness of obeticholic acid (OCA) as a second-line treatment, alongside
Autor:
Subashini Chandrapalan, Jessica K Dyson, Laura Haigh, William Taylor, Stuart McPherson, Mohammed Hussien, Sophia Oxenburgh, Quentin M. Anstee, Naw April Phaw, Kate Hallsworth, Timothy Hardy, Steven Masson, David Beaton, Sarah Galbraith, Dina Mansour, Shi Looi, Louise Macdougall, Phey Shen Lee, Alaa Ebraheem, Laura J Neilson
Publikováno v:
Frontline Gastroenterology
BackgroundNon-alcoholic fatty liver disease (NAFLD) is common and is associated with liver-related and cardiovascular-related morbidity. Our aims were: (1) to review the current management of patients with NAFLD attending hospital clinics in North Ea
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 15:235-241
Introduction: Patients with cholestatic diseases may develop fatigue and cognitive symptoms. The impact of symptom burden may be significant in some patients. To date, there are no effective pharmacological therapies to improve cognitive symptoms or
Publikováno v:
HPB. 22:1102-1111
Background Despite increasing reports of pregnancy in liver transplant recipients, questions remain about the impact of transplantation in pregnancy. Methods This systematic review was performed according to PRISMA guidelines and eligible studies wer
Autor:
Richard Taubert, George N. Dalekos, Marcial Sebode, Ye Htun Oo, David H. Adams, María-Carlota Londoño, Falk F. R. Buettner, Patrick Behrendt, Christoph Schramm, Jana Diestelhorst, Bastian Engel, Michael Hust, Jessica K Dyson, Martin Stangel, Benjamin Maasoumy, Piotr Milkiewicz, Elmar Jaeckel, N.T. Baerlecken, Maren Schubert, Julia Beimdiek, Heiner Wedemeyer, Michael P. Manns, Luigi Muratori, Sarah Habes, Kurt-Wolfram Sühs, Amédée Renand, Ansgar W. Lohse, Claudine Lalanne, Danny Jonigk, Maciej K. Janik, Joost P.H. Drenth, Katharina Luise Hupa-Breier, Isabel Graupera, Stefan Dübel, Torsten Witte, Simon Pape, Mario Thevis, Kalliopi Zachou
Publikováno v:
Hepatology 75(1), 13-27 (2022). doi:10.1002/hep.32134
Hepatology
Hepatology, 75, 13-27
Hepatology, 75, 1, pp. 13-27
Hepatology
Hepatology, 75, 13-27
Hepatology, 75, 1, pp. 13-27
Hepatology 75(1), 13-27 (2022). doi:10.1002/hep.32134
Published by Wolters Kluwer Health, [Alphen aan den Rijn]
Published by Wolters Kluwer Health, [Alphen aan den Rijn]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8df9272f39193a7b77dc47341f95ab0
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/252186
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/252186